<!DOCTYPE html>
<html lang="zh">
<head>
  <meta charset="UTF-8">
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <title>Application of Immune Checkpoint Inhibitors in Cancer - PMC</title>
  <style>
    body {
      font-family: "Helvetica Neue", "Noto Sans TC", sans-serif;
      max-width: 720px;
      margin: 2em auto;
      padding: 0 1em;
      color: #333;
      line-height: 1.8;
      background: #fff;
    }
    h1, h2, h3 {
      text-align: center;
      color: #222;
    }
    .lang-switcher {
      text-align: center;
      margin-bottom: 2em;
    }
    .lang-btn {
      margin: 0 0.5em;
      padding: 0.4em 1em;
      border: none;
      background-color: #eee;
      border-radius: 4px;
      cursor: pointer;
      font-weight: bold;
    }
    .lang-btn.active {
      background-color: #007acc;
      color: white;
    }
    ul {
      padding-left: 1.2em;
    }
    a {
      color: #007acc;
      text-decoration: none;
    }
    a:hover {
      text-decoration: underline;
    }
    img {
      max-width: 100%;
      height: auto;
    }
    .share-block {
      text-align: center;
      margin: 1em 0 2em;
      font-size: 0.95em;
    }
    .share-block a svg {
      width: 24px;
      height: 24px;
      display: inline-block;
      vertical-align: middle;
      margin: 0 0.4em;
      transition: transform 0.2s ease;
      cursor: pointer;
    }
    .share-block a svg:hover {
      transform: scale(1.2);
    }
  </style>

</head>
<body>
  <h1>Application of Immune Checkpoint Inhibitors in Cancer - PMC</h1>
  
  <div class="share-block">
    <span>üîó ÂàÜ‰∫´ÈÄôÁØáÊëòË¶ÅÔºö</span>
    <a href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fbreastcancer-tech.github.io%2Fbreast-cancer%2Farticles%2Fapplication-of-immune-checkpoint-inhibitors-in-cancer-pmc-summary.html" target="_blank" title="Facebook">
      <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512"><!--!Font Awesome Free 6.7.2 by @fontawesome - https://fontawesome.com License - https://fontawesome.com/license/free Copyright 2025 Fonticons, Inc.--><path d="M512 256C512 114.6 397.4 0 256 0S0 114.6 0 256C0 376 82.7 476.8 194.2 504.5V334.2H141.4V256h52.8V222.3c0-87.1 39.4-127.5 125-127.5c16.2 0 44.2 3.2 55.7 6.4V172c-6-.6-16.5-1-29.6-1c-42 0-58.2 15.9-58.2 57.2V256h83.6l-14.4 78.2H287V510.1C413.8 494.8 512 386.9 512 256h0z"/></svg>
    </a>
    <a href="https://x.com/intent/tweet?url=https%3A%2F%2Fbreastcancer-tech.github.io%2Fbreast-cancer%2Farticles%2Fapplication-of-immune-checkpoint-inhibitors-in-cancer-pmc-summary.html&text=Application%20of%20Immune%20Checkpoint%20Inhibitors%20in%20Cancer%20-%20PMC" target="_blank" title="X">
      <svg xmlns="http://www.w3.org/2000/svg" x="0px" y="0px" width="100" height="100" viewBox="0 0 50 50">
<path d="M 11 4 C 7.134 4 4 7.134 4 11 L 4 39 C 4 42.866 7.134 46 11 46 L 39 46 C 42.866 46 46 42.866 46 39 L 46 11 C 46 7.134 42.866 4 39 4 L 11 4 z M 13.085938 13 L 21.023438 13 L 26.660156 21.009766 L 33.5 13 L 36 13 L 27.789062 22.613281 L 37.914062 37 L 29.978516 37 L 23.4375 27.707031 L 15.5 37 L 13 37 L 22.308594 26.103516 L 13.085938 13 z M 16.914062 15 L 31.021484 35 L 34.085938 35 L 19.978516 15 L 16.914062 15 z"></path></svg>
    </a>
    <a href="https://www.threads.net/intent/post?url=https%3A%2F%2Fbreastcancer-tech.github.io%2Fbreast-cancer%2Farticles%2Fapplication-of-immune-checkpoint-inhibitors-in-cancer-pmc-summary.html&text=Application%20of%20Immune%20Checkpoint%20Inhibitors%20in%20Cancer%20-%20PMC" target="_blank" title="Threads">
      <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 448 512"><!--!Font Awesome Free 6.7.2 by @fontawesome - https://fontawesome.com License - https://fontawesome.com/license/free Copyright 2025 Fonticons, Inc.--><path d="M64 32C28.7 32 0 60.7 0 96V416c0 35.3 28.7 64 64 64H384c35.3 0 64-28.7 64-64V96c0-35.3-28.7-64-64-64H64zM294.2 244.3c19.5 9.3 33.7 23.5 41.2 40.9c10.4 24.3 11.4 63.9-20.2 95.4c-24.2 24.1-53.5 35-95.1 35.3h-.2c-46.8-.3-82.8-16.1-106.9-46.8C91.5 341.8 80.4 303.7 80 256v-.1-.1c.4-47.7 11.5-85.7 33-113.1c24.2-30.7 60.2-46.5 106.9-46.8h.2c46.9 .3 83.3 16 108.2 46.6c12.3 15.1 21.3 33.3 27 54.4l-26.9 7.2c-4.7-17.2-11.9-31.9-21.4-43.6c-19.4-23.9-48.7-36.1-87-36.4c-38 .3-66.8 12.5-85.5 36.2c-17.5 22.3-26.6 54.4-26.9 95.5c.3 41.1 9.4 73.3 26.9 95.5c18.7 23.8 47.4 36 85.5 36.2c34.3-.3 56.9-8.4 75.8-27.3c21.5-21.5 21.1-47.9 14.2-64c-4-9.4-11.4-17.3-21.3-23.3c-2.4 18-7.9 32.2-16.5 43.2c-11.4 14.5-27.7 22.4-48.4 23.5c-15.7 .9-30.8-2.9-42.6-10.7c-13.9-9.2-22-23.2-22.9-39.5c-1.7-32.2 23.8-55.3 63.5-57.6c14.1-.8 27.3-.2 39.5 1.9c-1.6-9.9-4.9-17.7-9.8-23.4c-6.7-7.8-17.1-11.8-30.8-11.9h-.4c-11 0-26 3.1-35.6 17.6l-23-15.8c12.8-19.4 33.6-30.1 58.5-30.1h.6c41.8 .3 66.6 26.3 69.1 71.8c1.4 .6 2.8 1.2 4.2 1.9l.1 .5zm-71.8 67.5c17-.9 36.4-7.6 39.7-48.8c-8.8-1.9-18.6-2.9-29-2.9c-3.2 0-6.4 .1-9.6 .3c-28.6 1.6-38.1 15.5-37.4 27.9c.9 16.7 19 24.5 36.4 23.6l-.1-.1z"/></svg>
    </a>
  </div>

  <div style="text-align: center;"><img src="https://www.discoverphds.com/wp-content/uploads/elementor/thumbs/What-is-Research-Purpose-of-Research-phul4s3cbwe0xam190dnc4kz3z616ajmfkygodcdqg.png" alt="News Cover Image" style="max-width: 100%; height: auto; border-radius: 12px; margin-bottom: 1.5em;"></div>
  <div class="lang-switcher">
    <button class="lang-btn active" data-lang="zh">‰∏≠Êñá</button><button class="lang-btn " data-lang="en">English</button><button class="lang-btn " data-lang="jp">Êó•Êú¨Ë™û</button>
  </div>
  
  <div class="ads-block" style="margin: 2.5em 0; position: relative; text-align: center;">
    <a href="https://cancerfree.io/" target="_blank" style="display: inline-block; position: relative;">
      <img src="https://cancerfree.io/wp-content/uploads/2024/10/logo-v3.0-TC.png" alt="Advertisement" style="width: 100%; border-radius: 12px; box-shadow: 0 2px 6px rgba(0,0,0,0.1);">
      <div style="
        position: absolute;
        top: 8px;
        right: 8px;
        background: rgba(0, 0, 0, 0.6);
        color: white;
        font-size: 0.75rem;
        padding: 2px 6px;
        border-radius: 4px;
        font-weight: bold;
        letter-spacing: 0.5px;
      ">
        Âª£Âëä
      </div>
    </a>
  </div>
  
  <div class="lang-content" data-lang="zh" style="">Okay, I'm ready to process the provided text. It appears to be a list of references related to cancer immunotherapy. Here's a breakdown of what I can do with this information, and how I can present it in a more organized way.

**What I can do:**

*   **Extract Key Information:** I can extract the following for each reference:
    *   Authors
    *   Title
    *   Journal
    *   Year
    *   Volume/Issue (if available)
    *   Page Numbers (if available)
    *   DOI (Digital Object Identifier)
    *   PubMed ID (PMID)
*   **Format the References:** I can reformat the references into a consistent citation style (e.g., APA, MLA, Chicago).
*   **Summarize Trends:** I can analyze the titles and abstracts (if available) to identify common themes and trends in cancer immunotherapy research.
*   **Create a Bibliography:** I can compile the extracted information into a properly formatted bibliography.

**Here's a formatted list of the references, based on the information provided.  I'm doing my best to infer the missing information.  Please note that some fields may be incomplete due to the limited data in the original text.**

**References**

1.  **Yarchoan, M., Gane, E. J., Marron, T. U., et al. (2024).** Personalized Neoantigen Vaccine and Pembrolizumab in Advanced Hepatocellular Carcinoma A Phase 12 Trial. *Nature Medicine*, *30*(4), 1044-1053. DOI: 10.1038/s41591-024-02894-y. PMID: 38584166.
2.  **Tang, S., Tang, R., Chen, G., et al. (2024).** Personalized Neoantigen Hydrogel Vaccine Combined with PD1 and CTLA4 Double Blockade Elicits Antitumor Response in Liver Metastases by Activating Intratumoral CD8CD69 T Cells. *Journal for Immunotherapy of Cancer*, *12*(12). DOI: 10.1136/jitc2024009543. PMID: 39694701.
3.  **Gou, Q., Yan, B., Duan, Y., et al. (2024).** Ubiquitination of CD47 Regulates Innate AntiTumor Immune Response. *Advanced Science*, e2412205. DOI: 10.1002/advs.202412205. PMID: 39665172.
4.  **Wei, J., Li, W., Zhang, P., Guo, F., & Liu, M. (2024).** Current Trends in Sensitizing Immune Checkpoint Inhibitors for Cancer Treatment. *Molecular Cancer*, *23*(1), 279. DOI: 10.1186/s12943-024-021795. PMID: 39725966.
5.  **Xie, Y., Liu, Y., Lin, M., et al. (2024).** Targeting ATM Enhances Radiation Sensitivity of Colorectal Cancer by Potentiating Radiationinduced Cell Death and Antitumor Immunity. *Journal of Advanced Research*. DOI: 10.1016/j.jare.2024.12.023. PMID: 39708961.
6.  **Zhan, Y., Tian, F., Fan, W., et al. (2024).** Targeting piRNA137463 Inhibits Tumor Progression and Boosts Sensitivity to Immune Checkpoint Blockade via De Novo Cholesterol Biosynthesis in Lung Adenocarcinoma. *Advanced Science*, e2414100. DOI: 10.1002/advs.202414100. PMID: 39692168.

**Notes:**

*   The journal names are often abbreviated.
*   Volume and issue numbers are missing for some references.
*   Page numbers are missing for some references.
*   I'm assuming a standard journal format for the missing information.

**To help me improve the formatting and extraction, could you tell me:**

*   **What citation style do you prefer?** (e.g., APA, MLA, Chicago)
*   **Are there any specific fields you want me to prioritize?**
*   **Do you have access to the full text of these articles?** (This would allow me to extract more information.)</div><div class="lang-content" data-lang="en" style="display: none;">Okay, here's a breakdown of the provided text, focusing on extracting key information and organizing it.  I'm aiming to provide a structured summary of the research trends and findings described.

**Overall Theme:** The text highlights recent advancements and emerging strategies in cancer immunotherapy, particularly focusing on overcoming resistance to existing checkpoint inhibitors and improving treatment efficacy.

**I. Personalized Immunotherapy & Vaccines**

*   **Yarchoan et al. (Nature Medicine, 2024):** A Phase 1/2 trial combining a personalized neoantigen vaccine with pembrolizumab (an immune checkpoint inhibitor) showed promise in advanced hepatocellular carcinoma (HCC).
*   **Tang et al. (Journal for Immunotherapy of Cancer, 2024):**  A personalized neoantigen hydrogel vaccine, combined with PD-1 and CTLA-4 blockade, activated intratumoral CD8+ T cells and elicited an antitumor response in liver metastases.
*   **Zhan et al. (Advanced Science, 2024):** Targeting piRNA137463 inhibits tumor progression and boosts sensitivity to immune checkpoint blockade via de novo cholesterol biosynthesis in lung adenocarcinoma.

**II. Overcoming Resistance & Combination Therapies**

*   **Wei et al. (Molecular Cancer, 2024):** Review of current trends in sensitizing immune checkpoint inhibitors for cancer treatment.
*   **Xie et al. (Journal of Advanced Research, 2024):** Targeting ATM enhances radiation sensitivity of colorectal cancer by potentiating radiation-induced cell death and antitumor immunity.
*   **Gou et al. (Advanced Science, 2024):** Targeting piRNA137463 inhibits tumor progression and boosts sensitivity to immune checkpoint blockade via de novo cholesterol biosynthesis in lung adenocarcinoma.

**III. Mechanisms & Novel Targets**

*   **Zhang et al. (Trends in Cancer, 2024):**  Discusses the reciprocal regulation between autophagy and immune checkpoint pathways, highlighting a potential mechanism of resistance.
*   **Gou et al. (Advanced Science, 2024):** Ubiquitination of CD47 regulates innate anti-tumor immune response.

**IV. Data & Availability**

*   **Data Availability Statement:** The authors report having nothing to report regarding data.

**Key Trends & Takeaways:**

*   **Personalized Medicine is Crucial:**  Neoantigen vaccines and tailored therapies are showing significant promise.
*   **Combination Approaches are Essential:** Combining checkpoint inhibitors with other treatments (radiation, vaccines, targeted therapies) is a major focus.
*   **Understanding Resistance Mechanisms:** Research is actively investigating why tumors become resistant to immunotherapy and developing strategies to overcome this.
*   **Novel Targets are Being Explored:**  Researchers are identifying new molecular targets (e.g., ATM, piRNA137463, CD47) to improve immunotherapy efficacy.
*   **Metabolic Pathways are Important:**  The role of metabolic pathways (e.g., cholesterol biosynthesis) in immune response is gaining attention.



**Note:** This is a summary based solely on the provided text.  Each citation represents a full research article with much more detail.</div><div class="lang-content" data-lang="jp" style="display: none;">Okay, I'm ready to process the provided text. Here's a breakdown of the information extracted from the provided text, which appears to be a list of research article citations related to cancer immunotherapy.

**Overall Structure:**

The text is a list of research article citations, each formatted similarly. Each entry includes:

*   **Authors** (usually a few names)
*   **Article Title**
*   **Journal Name**
*   **Volume, Issue, and Page Numbers**
*   **DOI (Digital Object Identifier)**
*   **PubMed ID (PMID)**
*   **Google Scholar Link (sometimes)**
*   **Associated Data Section (at the end, with a Data Availability Statement)**

**Here's a summarized list of the articles, extracted from the text. I'm presenting them in the order they appear in the original text:**

1.  **Authors:** Yarchoan M., Gane E. J., Marron T. U., et al.
    **Title:** Personalized Neoantigen Vaccine and Pembrolizumab in Advanced Hepatocellular Carcinoma A Phase 12 Trial
    **Journal:** Nature Medicine
    **Volume:** 30
    **Issue:** 4
    **Pages:** 1044-1053
    **DOI:** 10.1038/s41591-024-02894-y
    **PMID:** 38584166

2.  **Authors:** Tang S., Tang R., Chen G., et al.
    **Title:** Personalized Neoantigen Hydrogel Vaccine Combined with PD1 and CTLA4 Double Blockade Elicits Antitumor Response in Liver Metastases by Activating Intratumoral CD8CD69 T Cells
    **Journal:** Journal for Immunotherapy of Cancer
    **Volume:** 12
    **Issue:** 12
    **PMID:** 39694701
    **DOI:** 10.1136/jitc2024009543

3.  **Authors:** Gou Q., Yan B., Duan Y., et al.
    **Title:** Ubiquitination of CD47 Regulates Innate AntiTumor Immune Response
    **Journal:** Advanced Science
    **Pages:** e2412205
    **DOI:** 10.1002/advs.202412205
    **PMID:** 39665172

4.  **Authors:** Wei J., Li W., Zhang P., Guo F., and Liu M.
    **Title:** Current Trends in Sensitizing Immune Checkpoint Inhibitors for Cancer Treatment
    **Journal:** Molecular Cancer
    **Volume:** 23
    **Issue:** 1
    **Pages:** 279
    **DOI:** 10.1186/s12943-024-021795
    **PMID:** 39725966

5.  **Authors:** Xie Y., Liu Y., Lin M., et al.
    **Title:** Targeting ATM Enhances Radiation Sensitivity of Colorectal Cancer by Potentiating Radiationinduced Cell Death and Antitumor Immunity
    **Journal:** Journal of Advanced Research
    **DOI:** 10.1016/j.jare.2024.12.023
    **PMID:** 39708961

6.  **Authors:** Zhan Y., Tian F., Fan W., et al.
    **Title:** Targeting piRNA137463 Inhibits Tumor Progression and Boosts Sensitivity to Immune Checkpoint Blockade via De Novo Cholesterol Biosynthesis in Lung Adenocarcinoma
    **Journal:** Advanced Science
    **Pages:** e2414100
    **DOI:** 10.1002/advs.202414100
    **PMID:** 39692168

**Associated Data Section:**

*   **Data Availability Statement:** "The authors have nothing to report."

**Important Notes:**

*   **Missing Information:** Some entries are missing specific details like volume, issue, or page numbers.
*   **Formatting:** The formatting is somewhat inconsistent.
*   **News URL:** There's a URL at the very end that seems unrelated to the article citations.

Let me know if you'd like me to perform any other operations on this data, such as:

*   Extracting specific information (e.g., all DOIs)
*   Sorting the list
*   Converting the data into a different format (e.g., CSV)</div>
  <p style="text-align:center; margin-top: 2em;">
    <a href="./application-of-immune-checkpoint-inhibitors-in-cancer-pmc-seo.html">üëâ Êü•ÁúãÂéüÊñá / Full Article</a>
  </p>
  <script>
    document.querySelectorAll('.lang-btn').forEach(btn => {
      btn.addEventListener('click', () => {
        const lang = btn.dataset.lang;
        document.querySelectorAll('.lang-btn').forEach(b => b.classList.remove('active'));
        btn.classList.add('active');
        document.querySelectorAll('.lang-content').forEach(div => {
          div.style.display = div.dataset.lang === lang ? '' : 'none';
        });
      });
    });
  </script>
</body>
</html>